Skip to main content
Top
Published in: Urolithiasis 6/2022

30-09-2022 | Original Article

Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes

Authors: Jeffrey A. Wesson, Roman Zenka, Jody Lulich, Jessica Eisenhauer, Carley Davis

Published in: Urolithiasis | Issue 6/2022

Login to get access

Abstract

Despite its critical nature, the role of matrix in calcium oxalate stone formation is poorly understood. The wide diversity of proteins comprising matrix has contributed to the ambiguity. This study compares the protein distributions measured by mass spectrometry in human calcium oxalate stone matrix to that observed in cat stone matrix, because cats share many clinical characteristics of their stone disease with humans. The observed protein distributions were analyzed in the context of a recent model based on the aggregation of strongly anionic and strongly cationic proteins which includes selective adsorption of other proteins based on total charge. Matrix protein distributions shared many common features between species, including enrichment of both strongly anionic and strongly cationic proteins, increased total charge in matrix proteins compared to urine proteins, and a high degree of similarity of prominent strongly anionic proteins in the matrix of both species. However, there was weaker overlap of the specific dominant proteins in other regions of the net charge distribution. Collectively, these observations support the conceptual model where the strongly anionic proteins associate most strongly with the calcium oxalate crystal surfaces, while the other proteins associate with the strongly anionic proteins through non-specific, charge interactions with each other to create stones. Also, cats appear to be the best animal model of human stone disease identified to date based on these similarities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152CrossRef Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152CrossRef
2.
go back to reference Worcester EM (1996) Inhibitors of stone formation. [Review] [74 refs]. Sem Nephrol 16:474–486 Worcester EM (1996) Inhibitors of stone formation. [Review] [74 refs]. Sem Nephrol 16:474–486
3.
go back to reference Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci 9:1450–1482CrossRef Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci 9:1450–1482CrossRef
4.
go back to reference Khan SR (1997) Animal models of kidney stone formation: an analysis. [Review] [52 refs]. World J Urol 15:236–243CrossRef Khan SR (1997) Animal models of kidney stone formation: an analysis. [Review] [52 refs]. World J Urol 15:236–243CrossRef
9.
go back to reference Lulich J (2016) Microanatomy of feline nephrolithiasis. American College of Veterinary Internal Medicine Forum, Denver, p 2016 Lulich J (2016) Microanatomy of feline nephrolithiasis. American College of Veterinary Internal Medicine Forum, Denver, p 2016
13.
go back to reference Merchant ML, Cummins TD, Wilkey DW et al (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol - Ren Physiol 295:F1254–F1258CrossRef Merchant ML, Cummins TD, Wilkey DW et al (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol - Ren Physiol 295:F1254–F1258CrossRef
16.
go back to reference Boyce WH, Garvey FK (1956) The amount and nature of the organic matrix in urinary calculi: a review. J Urol 76:213–227CrossRef Boyce WH, Garvey FK (1956) The amount and nature of the organic matrix in urinary calculi: a review. J Urol 76:213–227CrossRef
17.
go back to reference Worcester EM, Beshensky AM, Hung L (1993) Nephrocalcin (NC) levels and calcium oxalate (CaOx) crystal growth inhibition in the urine of hypercalciuric and normocalciuric calcium stone formers (SF). JAmerSocNeph 4:716–716 Worcester EM, Beshensky AM, Hung L (1993) Nephrocalcin (NC) levels and calcium oxalate (CaOx) crystal growth inhibition in the urine of hypercalciuric and normocalciuric calcium stone formers (SF). JAmerSocNeph 4:716–716
19.
go back to reference Ryall RL, Grover PK, Stapleton AM et al (1995) The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 89:533–541CrossRef Ryall RL, Grover PK, Stapleton AM et al (1995) The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 89:533–541CrossRef
20.
go back to reference Hess B (1994) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398PubMed Hess B (1994) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398PubMed
22.
go back to reference Wesson JA, Ganne V, Beshensky AM, Kleinman JG (2005) Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 33:206–212CrossRef Wesson JA, Ganne V, Beshensky AM, Kleinman JG (2005) Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 33:206–212CrossRef
37.
go back to reference Shiraga H, Min W, VanDusen WJ et al (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U A 89:426–430CrossRef Shiraga H, Min W, VanDusen WJ et al (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U A 89:426–430CrossRef
38.
go back to reference Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci U S A 102:267–272CrossRef Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci U S A 102:267–272CrossRef
39.
go back to reference Guo S, Ward MD, Wesson JA (2002) Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir 18:4284–4291CrossRef Guo S, Ward MD, Wesson JA (2002) Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir 18:4284–4291CrossRef
Metadata
Title
Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes
Authors
Jeffrey A. Wesson
Roman Zenka
Jody Lulich
Jessica Eisenhauer
Carley Davis
Publication date
30-09-2022
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 6/2022
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-022-01363-w

Other articles of this Issue 6/2022

Urolithiasis 6/2022 Go to the issue